Table 1.

Trials Associated with EBV-DNA and Nasopharyngeal Carcinoma

Therapy selection or decision of response for therapy
NCT02135042	Recruiting	Stage II–IV NPC	The utility of plasma EBV DNA for selection of adjuvant chemotherapy after chemoradiation or radiation
NCT03668730	Active, not recruiting	Stage III NPC	The utility of plasma EBV DNA and radiographic examination for selection of dose of radiation after induction chemotherapy
NCT01365208	Completed	Advanced NPC	The utility of the combination of plasma EBV DNA and PET-CT for early detection of drug response
Prognosis speculation
NCT03981224	Completed	High-risk NPC patient with posit-radiation	The utility of plasma EBV DNA confirmation test for diagnostic sensitivity of relapse detection and predict survivals
NCT03601390	Completed	Locally advanced NPC	The utility of combining PET/CT and EBV DNA to evaluate the hazard of progression
NCT03973723	Completed	NPC after curative treatment	The impact of monitoring plasma EBV DNA for early detection of tumor relapse

Abbreviation: NPC, nasopharyngeal carcinoma.